Baramee Apiwat, Coppin Alexandra, Mortuaire Marlène, Pelinski Lydie, Tomavo Stanislas, Brocard Jacques
Laboratoire de Catalyse de Lille, Groupe de Synthèses Asymétriques et Molécules Thérapeutiques, UMR CNRS 8010, ENSCL, USTL, Villeneuve d'Ascq, France.
Bioorg Med Chem. 2006 Mar 1;14(5):1294-302. doi: 10.1016/j.bmc.2005.09.054. Epub 2005 Oct 18.
Fourteen ferrocenyl aminohydroxynaphthoquinones, analogues of atovaquone, were synthesized from the hydroxynaphthoquinone core. These novel atovaquone derivatives were tested for their in vitro activity against two apicomplexan parasites of medical importance, Toxoplasma gondii and Plasmodium falciparum, including resistant strains to atovaquone (T. gondii) and chloroquine (P. falciparum). Three of these ferrocenic atovaquone derivatives composed of the hydroxynaphthoquinone core plus an amino-ferrocenic group and an aliphatic chain with 6-8 carbon atoms were found to be significantly active against T. gondii. Moreover, these novel compounds were also effective against the atovaquone-resistant strain of T. gondii (Ato(R)).
从羟基萘醌核心合成了14种阿苯达喹类似物——二茂铁基氨基羟基萘醌。对这些新型阿苯达喹衍生物进行了体外活性测试,以检测其对两种具有医学重要性的顶复门寄生虫——刚地弓形虫和恶性疟原虫的活性,其中包括对阿苯达喹耐药的刚地弓形虫菌株和对氯喹耐药的恶性疟原虫菌株。发现其中三种由羟基萘醌核心加上一个氨基二茂铁基团和一条含有6 - 8个碳原子的脂肪链组成的二茂铁基阿苯达喹衍生物对刚地弓形虫具有显著活性。此外,这些新型化合物对阿苯达喹耐药的刚地弓形虫菌株(Ato(R))也有效。